07-Feb-2023 | Zion Market Research
Some of key players in Neuroblastoma Treatment market are United Therapeutics Corporation, Apeiron Biologics AG, Baxter, Cellectar Biosciences, Inc., Pfizer, Inc., MacroGenics, Inc., Bayer AG, Sun Pharmaceutical Industries, Inc., and Sartorius AG. These players are set to bolster the development of Neuroblastoma Treatment market.
According to analysts at Zion Market Research, the Neuroblastoma Treatment market accounted for USD 437.1 Million in 2020 and is expected to reach USD 600.5 Million by 2028, growing at a CAGR of more than 4.1% from 2021 to 2028.
This review is based on a report by Zion Market Research, titled “Neuroblastoma Treatment Market By Therapy (Surgery, Chemotherapy, Immunotherapy, and Radiotherapy), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Drug Stores): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028.”
Neuroblastoma is rare cancer but it’s the most common cancer in babies. According to health organization in the United States, about 800 children are diagnosed with neuroblastoma. It almost always develops before age 5. It can occur in babies before they are born. Neuroblastoma is very rare in children over age 10. There are four stages in neuroblastoma such as Stage L1, Stage L2, Stage M, and Stage MS. Neuroblastoma happens when immature nerve tissues (neuroblasts) grow out of control. The cells become abnormal and continue growing and dividing, forming a tumor. A genetic mutation (a change in the neuroblast’s genes) causes the cells to grow and divide uncontrollably. Healthcare providers are not sure what causes the genetic mutation and still there is no technology to find the main cause for this cancer to grow. Due to this reason the need for the treatment is necessary and government bodies and healthcare companies are investing funds for research and development for this treatment. In coming years due to higher birthrate the need for this treatment is the major factor concerning the growth for neuroblastoma treatment market.
North America dominated the market in 2020, accounting for over 35.0% share of the global revenue. The market growth is due to factors such as the high prevalence of neuroblastoma in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region the United States has the maximum share due to supportive healthcare policies, a high number of patients, and a developed healthcare market. According to the American Cancer Society’s Cancer Statistics, nearly 800 new cases of neuroblastoma are reported in the United States every year. The above statistics prove that the high prevalence of the disease is boosting the market in the region.
Browse the full “Neuroblastoma Treatment Market By Therapy (Surgery, Chemotherapy, Immunotherapy, And Radiotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Drug Stores): Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028.” Report at https://www.zionmarketresearch.com/report/neuroblastoma-treatment-market
By Distribution Channel
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651